Overview

The 10th Annual West Oncology Conference will serve as a valuable forum for presenting and discussing new research findings in oncology education.

Learners will be provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting will be an in-person conference with on-demand access for registered attendees.

Learning Objectives

• Identify novel targeted and immunologic approaches to therapy for various cancers
• Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer
• Identify optimal therapies for patients and managing and mitigating side effects
• Describe findings from recent clinical trials evaluating immunotherapies
• Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life
• Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients

Accreditation

Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.